Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care.
Adimadhyam S, Barreto EF, Cocoros NM, Toh S, Brown JS, Maro JC, Corrigan-Curay J, Dal Pan GJ, Ball R, Martin D, Nguyen M, Platt R, Li X. Adimadhyam S, et al. Among authors: platt r. J Am Soc Nephrol. 2020 Nov;31(11):2506-2516. doi: 10.1681/ASN.2020040526. Epub 2020 Oct 19. J Am Soc Nephrol. 2020. PMID: 33077615 Free PMC article. Review.
The FDA Sentinel Initiative - An Evolving National Resource.
Platt R, Brown JS, Robb M, McClellan M, Ball R, Nguyen MD, Sherman RE. Platt R, et al. N Engl J Med. 2018 Nov 29;379(22):2091-2093. doi: 10.1056/NEJMp1809643. N Engl J Med. 2018. PMID: 30485777 No abstract available.
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System.
Cocoros NM, Fuller CC, Adimadhyam S, Ball R, Brown JS, Dal Pan GJ, Kluberg SA, Lo Re V 3rd, Maro JC, Nguyen M, Orr R, Paraoan D, Perlin J, Poland RE, Driscoll MR, Sands K, Toh S, Yih WK, Platt R; And the FDA-Sentinel COVID-19 Working Group. Cocoros NM, et al. Among authors: platt r. Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):827-837. doi: 10.1002/pds.5240. Epub 2021 Apr 18. Pharmacoepidemiol Drug Saf. 2021. PMID: 33797815 Free PMC article. Review.
Is size the next big thing in epidemiology?
Toh S, Platt R. Toh S, et al. Among authors: platt r. Epidemiology. 2013 May;24(3):349-51. doi: 10.1097/EDE.0b013e31828ac65e. Epidemiology. 2013. PMID: 23549179 No abstract available.
Big data in epidemiology: too big to fail?
Toh S, Platt R. Toh S, et al. Among authors: platt r. Epidemiology. 2013 Nov;24(6):939. doi: 10.1097/EDE.0b013e3182a71390. Epidemiology. 2013. PMID: 24077001 No abstract available.
FDA-Catalyst-Using FDA's Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial.
Cocoros NM, Pokorney SD, Haynes K, Garcia C, Al-Khalidi HR, Al-Khatib SM, Archdeacon P, Goldsack JC, Harkins T, Lin ND, Martin D, McCall D, Nair V, Parlett L, Temple R, McMahill-Walraven C, Granger CB, Platt R. Cocoros NM, et al. Among authors: platt r. Clin Trials. 2019 Feb;16(1):90-97. doi: 10.1177/1740774518812776. Epub 2018 Nov 16. Clin Trials. 2019. PMID: 30445835
Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial.
Garcia CJ, Haynes K, Pokorney SD, Lin ND, McMahill-Walraven C, Nair V, Parlett L, Martin D, Al-Khalidi HR, McCall D, Granger CB, Platt R, Cocoros NM. Garcia CJ, et al. Among authors: platt r. Clin Trials. 2020 Aug;17(4):360-367. doi: 10.1177/1740774520928426. Epub 2020 Jun 26. Clin Trials. 2020. PMID: 32589056 Free PMC article.
1,194 results